Publications by authors named "Andy Chi"

Claim this Profile
D
DOD-BART: machine learning-based dose optimization design incorporating patient-level prognostic factors via Bayesian additive regression trees.
Yunqi Zhao, Rachael Liu, Jianchang Lin, Andy Chi, Simon Davies

J Biopharm Stat· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Practical considerations of utilizing propensity score methods in clinical development using real-world and historical data.
Qing Li, Jianchang Lin, Andy Chi, Simon Davies

Contemp Clin Trials· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Panoptic clinical review of the current and future treatment of relapsed/refractory T-cell lymphomas: Peripheral T-cell lymphomas.
Pier Luigi Zinzani, Vijayveer Bonthapally, Dirk Huebner, Richard Lutes, Andy Chi

Crit Rev Oncol Hematol· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Panoptic clinical review of the current and future treatment of relapsed/refractory T-cell lymphomas: Cutaneous T-cell lymphomas.
Pier Luigi Zinzani, Vijayveer Bonthapally, Dirk Huebner, Richard Lutes, Andy Chi

Crit Rev Oncol Hematol· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brentuximab vedotin compared with other therapies in relapsed/refractory Hodgkin lymphoma post autologous stem cell transplant: median overall survival meta-analysis.
Vijayveer Bonthapally, Hongbo Yang, Rajeev Ayyagari, Ruo-Ding Tan, Sean Cai, Andy Chi

Curr Med Res Opin· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brentuximab vedotin in relapsed/refractory Hodgkin lymphoma post-autologous transplant: meta-analysis versus historical data.
Vijayveer Bonthapally, Eric Wu, Alexander Macalalad, Hongbo Yang, Oluwatoyin Shonukan, Andy Chi

Curr Med Res Opin· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin's lymphoma at risk of relapse or progression (AETHERA): a randomised, double-blind, placebo-controlled, phase 3 trial.
Craig H Moskowitz, Auayporn Nademanee, Tamas Masszi, Edward Agura, Jerzy Holowiecki, Andy Chi

Lancet· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surgical reconstruction of severe forefoot derangement in a patient with traumatically acquired contralateral limb-length discrepancy: a case report.
Alexander Bonner, Carlton C Cranford, Rakesh Patel, Andy Chi, Shamir Bhikha

J Am Podiatr Med Assoc· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis